Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: An underrecognized problem in Asia?

Journal of Clinical Microbiology

Volumn 51, Issue 10, 2013, Pages 3308-3313

  Hawkey, Peter M ^a,b   Marriott, Clare ^c   Liu, Wen En ^d   Jian, Zi Juan ^d   Gao, Qian ^d   Ling, Thomas Kin Wah ^e   Chow, Viola ^e   So, Erica ^e   Chan, Raphael ^e   Hardy, Katie ^a,b   Xu, Li ^a   Manzoor, Susan ^f  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFAMANDOLE; CEFEPIME; CEFMENOXIME; CEFONICID; CEFOPERAZONE; CEFPIRAMIDE; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PAZUFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHINA; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLUSTER ANALYSIS; CROSS INFECTION; DIARRHEA; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MALE; MEDICAL RECORD; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; TEACHING HOSPITAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIA; CHINA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CLUSTER ANALYSIS; CROSS INFECTION; DIARRHEA; FECES; FEMALE; GENOTYPE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; RIBOTYPING;

EID: 84884740632     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00587-13     Document Type: Article

References (31)

1. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group. 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73.
2. Kuijper EJ, Coignard B, Tull P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. 2006. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 12(Suppl 6):2-18. (Pubitemid 44362038)
3. Balassiano IT, Yates EA, Domingues RM, Ferreira EO. 2012. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J. Med. Microbiol. 61:169-179.
4. Iwashima Y, Nakamura A, Kato H, Kato H, Wakimoto Y, Wakiyama N, Kaji C, Ueda R. 2010. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J. Infect. Chemother. 16:329-333.
5. Kim H, Jeong SH, Roh KH, Hong SG, Kim JW, Shin MG, Kim MN, Shin HB, Uh Y, Lee H, Lee K. 2010. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J. Lab. Med. 30: 491-497.
6. Jin K, Wang S, Huang Z, Lu S. 2010. Clostridium difficile infections in China. J. Biomed. Res. 24:411-416.
7. Huang H, Fang H, Weintraub A, Nord CE. 2009. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin. Microbiol. Infect. 15:1170-1173.
8. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE. 2008. Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China. Clin. Infect. Dis. 47:1606-1608.
9. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. 1999. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J. Clin. Microbiol. 37:461-463. (Pubitemid 29056430)
10. Yan Q, Zhang J, Chen C, Zhou H, DU P, Cui Z, Cen R, Liu L, Li W, Cao B, Lu J, Cheng Y. 2013. Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China. Epidemiol. Infect. 141:195-199.
11. Yuen KY, Woo PC, Liang RH, Chiu EK, Chen FF, Wong SS, Lau YL, Ha SY, Peiris JS, Siau H, Chan TK. 1998. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn. Microbiol. Infect. Dis. 30:75-81. (Pubitemid 28102860)
12. Wong SS, Ho PL, Woo PC, Yuen KY. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29:760-767. (Pubitemid 30256363)
13. Cheng VC, Yam WC, Chan JF, To KK, Ho PL, Yuen KY. 2009. Clostridium difficile ribotype 027 arrives in Hong Kong. Int. J. Antimicrob. Agents 34:492-493.
14. Chang KC, Leung CC, Yew WW, Lam FM, Ho PL, Chau CH, Cheng VC, Yuen KY. 2009. Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients. Int. J. Tuberc. Lung Dis. 13:341-346.
15. Lee JS, Auyeung TW. 2003. A comparison of two feeding methods in the alleviation of diarrhoea in older tube-fed patients: a randomised controlled trial. Age Ageing 32:388-393. (Pubitemid 36926602)
16. Cheng VC, Yam WC, Lam OT, Tsang JL, Tse EY, Siu GK, Chan JF, Tse H, To KK, Tai JW, Ho PL, Yuen KY. 2011. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 30:1371-1381.
17. Lam T, Yuk M, Tsang N, Wong M, Chuang S. 2012. Clostridium difficile infection outbreak in a male rehabilitation ward, Hong Kong (China), 2011. Western Pac. Surveill. Response J. 3:59-60. doi:10.5365/wpsar.2012. 3.4.001.
18. Lin YC, Huang YT, Tsai PJ, Lee TF, Lee NY, Liao CH, Lin SY, Ko WC, Hsueh PR. 2011. Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in Taiwan. Antimicrob. Agents Chemother. 55:1701-1705.
19. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, Pons JL. 2004. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. J. Clin. Microbiol. 42:5710-5714. (Pubitemid 39664357)
20. Manzoor SE, Tanner HE, Marriott CL, Brazier JS, Hardy KJ, Platt S, Hawkey PM. 2011. Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission. J. Clin. Microbiol. 49:3523-3530.
21. Galaydick J, Landon E, Weber SG, Xu Y, Sun D, Zhou J, Sun L, Sherer R. 2012. The prevalence of Clostridium difficile in Wuhan China. International Conference on Emerging and Infectious Diseases (ICEID), poster 348.
22. Hvistendahl M. 2012. Public health. China takes aim at rampant antibiotic resistance. Science 336:795.
23. Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J; ARHAI Antimicrobial Stewardship Group. 2012. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J. Antimicrob. Chemother. 67(Suppl 1):i51-i63.
24. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. 2011. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect. Dis. 11:692-701.
25. Cairns MD, Stabler RA, Shetty N, Wren BW. 2012. The continually evolving Clostridium difficile species. Future Microbiol. 7:945-957.
26. Shin BM, Kuak EY, Yoo SJ, Shin WC, Yoo HM. 2008. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn. Microbiol. Infect. Dis. 60:333-337. (Pubitemid 351380773)
27. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. 2007. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 28:932-940. (Pubitemid 47218272)
28. Goorhuis A, Legaria MC, van den Berg RJ, Harmanus C, Klaassen CH, Brazier JS, Lumelsky G, Kuijper EJ. 2009. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin. Microbiol. Infect. 15:1080-1086.
29. Pituch H, Brazier JS, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M. 2006. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. J. Med. Microbiol. 55:207-213. (Pubitemid 43201749)
30. Kato H, Ito Y, van den Berg RJ, Kuijper EJ, Arakawa Y. 2007. First isolation of Clostridium difficile 027 in Japan. Euro Surveill. 12:E070111.3.
31. Tae CH, Jung SA, Song HJ, Kim SE, Choi HJ, Lee M, Hwang Y, Kim H, Lee K. 2009. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J. Korean Med. Sci. 24:520-524.